Clinical Trials
3 trialsNCT04926181 2025-05-15
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
NCT02348281 2018-01-23
Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients
Fudan University
Phase 2 Terminated
NCT00918385 2014-10-29
ARS
Duke University
Phase 2 Terminated